Literature DB >> 16024886

Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study.

G Logroscino1, E Beghi, S Zoccolella, R Palagano, A Fraddosio, I L Simone, P Lamberti, V Lepore, L Serlenga.   

Abstract

BACKGROUND: While the incidence of amyotrophic lateral sclerosis (ALS) is similar across the world (range, 1.0 to 2.5/100,000), a latitude gradient from north to south has been observed.
OBJECTIVE: To determine the incidence of ALS in Puglia, a region of south eastern Italy, and to test the latitude gradient hypothesis comparing the present study with findings in studies conducted with the same design in a northern latitude.
METHODS: Puglia (4,086,613 residents in 2001) is the site of a multicentre-multisource prospective population based registry established in 1997. All incident ALS cases during the period 1998-99 were enrolled and followed up. Cases were classified using the first and the revised El Escorial criteria.
RESULTS: During the study period 130 cases were enrolled. The annual crude incidence for ALS in Puglia for the two year period 1998-99 was 1.6/100,000 (95% confidence interval, 1.3 to 1.9). The incidence was higher for men (incidence rate (IR) = 2.1 (1.7 to 2.7) than for women (IR = 1.2 (0.9 to 1.5)) in all age groups, with a male to female ratio of 1.6. For both men and women, the incidence increased through age 75 and declined rapidly afterwards. The mean annual incidence adjusted by age and sex to the 2001 Italian population was 1.7/100,000 (1.4 to 2.0).
CONCLUSIONS: ALS incidence is within a narrow range across countries, with a peak between 65 and 75 years and a higher incidence in men. A north to south latitude gradient of ALS incidence is not supported by the results of cohort studies.

Entities:  

Mesh:

Year:  2005        PMID: 16024886      PMCID: PMC1739746          DOI: 10.1136/jnnp.2004.039180

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  18 in total

1.  Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption.

Authors:  L M Nelson; V McGuire; W T Longstreth; C Matkin
Journal:  Am J Epidemiol       Date:  2000-01-15       Impact factor: 4.897

Review 2.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

3.  Gender and educational differences in smoking initiation rates in Spain from 1948 to 1992.

Authors:  Anna Schiaffino; Esteve Fernandez; Carme Borrell; Esteve Salto; Montse Garcia; Josep Maria Borras
Journal:  Eur J Public Health       Date:  2003-03       Impact factor: 3.367

4.  Sick individuals and sick populations.

Authors:  G Rose
Journal:  Int J Epidemiol       Date:  1985-03       Impact factor: 7.196

5.  Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS.

Authors:  P G Ince; J Evans; M Knopp; G Forster; H H M Hamdalla; S B Wharton; P J Shaw
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

6.  Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study.

Authors:  B J Traynor; M B Codd; B Corr; C Forde; E Frost; O M Hardiman
Journal:  Arch Neurol       Date:  2000-08

7.  Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984.

Authors:  S Yoshida; D W Mulder; L T Kurland; C P Chu; H Okazaki
Journal:  Neuroepidemiology       Date:  1986       Impact factor: 3.282

8.  Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998.

Authors:  Eric J Sorenson; Andrew P Stalker; Leonard T Kurland; Anthony J Windebank
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

9.  Changes in the incidence of amyotrophic lateral sclerosis in Israel.

Authors:  E Kahana; N Zilber
Journal:  Arch Neurol       Date:  1984-02

10.  Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy.

Authors:  G Rosati; L Pinna; E Granieri; I Aiello; R Tola; V Agnetti; A Pirisi; P de Bastiani
Journal:  Acta Neurol Scand       Date:  1977-03       Impact factor: 3.209

View more
  38 in total

Review 1.  Oxidative damage to RNA in aging and neurodegenerative disorders.

Authors:  Akihiko Nunomura; Paula I Moreira; Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

2.  Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP).

Authors:  Rosanna Tortelli; Massimiliano Copetti; Simona Arcuti; Marianna Tursi; Annalisa Iurillo; Maria Rosaria Barulli; Rosa Cortese; Rosa Capozzo; Eustachio D'Errico; Benoit Marin; Isabella Laura Simone; Giancarlo Logroscino
Journal:  J Neurol       Date:  2015-11-20       Impact factor: 4.849

Review 3.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

4.  Environmental toxins and neurodegenerative diseases: a challenge for epidemiologists.

Authors:  Beate Ritz
Journal:  Epidemiology       Date:  2006-01       Impact factor: 4.822

5.  ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy.

Authors:  Stefano Zoccolella; Ettore Beghi; Guerrino Palagano; Angela Fraddosio; Vito Guerra; Vito Lepore; Isabella Laura Simone; Paolo Lamberti; Luigi Serlenga; Giancarlo Logroscino
Journal:  J Neurol       Date:  2007-04-13       Impact factor: 4.849

6.  The epidemiology of motor neurone disease in two counties in the southwest of England.

Authors:  Ibrahim Imam; Susan Ball; Dave Wright; C Oliver Hanemann; John Zajicek
Journal:  J Neurol       Date:  2010-01-22       Impact factor: 4.849

7.  Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  S Fadilah Abdul Wahid; Zhe Kang Law; Nor Azimah Ismail; Nai Ming Lai
Journal:  Cochrane Database Syst Rev       Date:  2019-12-19

8.  Incidence of amyotrophic lateral sclerosis in Europe.

Authors:  Giancarlo Logroscino; Bryan J Traynor; Orla Hardiman; Adriano Chiò; Douglas Mitchell; Robert J Swingler; Andrea Millul; Emma Benn; Ettore Beghi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-08-25       Impact factor: 10.154

9.  Anaesthesia for ophthalmologic surgical procedures in a patient with advanced amyotrophic lateral sclerosis: a case report.

Authors:  Maciej M Kowalik; Tomasz Smiatacz; Robert Pajuro; Roman Skowroński; Hanna Trocha; Walenty Nyka; Krystyna Raczyńska; Maria Wujtewicz
Journal:  Cases J       Date:  2008-11-20

10.  Genome-wide association reveals three SNPs associated with sporadic amyotrophic lateral sclerosis through a two-locus analysis.

Authors:  Qiuying Sha; Zhaogong Zhang; Jennifer C Schymick; Bryan J Traynor; Shuanglin Zhang
Journal:  BMC Med Genet       Date:  2009-09-09       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.